Dutch Court Case On Humira Assesses Whether Its Price Was `Excessive’By Press Room10 May 2025 In a unique legal challenge, the Dutch Pharmaceutical Accountability Foundation is taking on the manufacturer of Humira (adalimumab), AbbVie, in…